Healthcare Data Broker Regulations: Laws, Compliance Requirements, and 2026 Updates

Healthcare data broker regulations are tightening as policymakers align patient privacy, interoperability, and AI oversight. This guide explains the laws you must follow, the compliance requirements to prioritize, and the practical 2026 updates influencing your program roadmap.

Use it to benchmark policies, vendor contracts, and product design across HIPAA, 42 CFR Part 2, information blocking rules, state data broker statutes, and emerging limits on bulk sensitive personal data transfers.

Federal Civil Enforcement Programs

What regulators are prioritizing

Federal civil enforcement focuses on unlawful disclosures, deceptive data practices, inadequate security, and obstruction of electronic health information exchange. Expect coordinated actions across privacy and interoperability regimes, with emphasis on auditable controls and timely corrective action.

42 CFR Part 2 and Substance Use Disorder Confidentiality

Because Substance Use Disorder Confidentiality under 42 CFR Part 2 imposes stricter protections than many other health privacy rules, you must implement granular consent management, redisclosure restrictions, and access segmentation. Map data flows so Part 2 records never leak into general datasets or analytics without valid consent or an applicable exception.

Information Blocking Enforcement

Information Blocking Enforcement now targets practices that unreasonably interfere with access, exchange, or use of electronic health information. Monitor your API behavior, fees, and licensing terms; document any practice that could slow data sharing, and maintain a clear exceptions log with evidence.

2026 action items

• Refresh risk assessments to reflect new enforcement themes, documenting recognized security practices for the Health Insurance Portability and Accountability Act.
• Adopt consent orchestration that separates 42 CFR Part 2 data from other records and records redisclosure decisions.
• Operationalize a rapid-review process for potential information blocking complaints and remediate root causes within defined SLAs.

State Data Broker Laws

Convergence and key differences

States increasingly require Data Broker Registration, disclosures about data categories and sources, and robust mechanisms for consumer access, deletion, and opt-out of sale or sharing. Definitions of “sale,” “sensitive data,” and “consumer” vary, so harmonize your controls to the strictest common denominator.

California’s SB 362 (Delete Act) highlights for 2026

California’s SB 362 expands registration obligations and streamlines consumer deletion across registered brokers. For 2026, prioritize scalable identity verification, end-to-end deletion workflows, and vendor propagation so removals persist across downstream processors and datasets.

Implementation playbook

• Centralize state registrations and automate renewal reminders; publish required disclosures with consistent taxonomy.
• Build a single pipeline for intake, authentication, fulfillment, and audit of rights requests across all applicable states.
• Continuously test that suppression and deletion propagate to analytic stores, backups, and third parties.

Updates to Privacy Standards

HIPAA modernization and alignment

Under the Health Insurance Portability and Accountability Act, regulators expect demonstrable security maturity, least-privilege access, and documented risk-based decisions. Align your privacy notices, BAAs, and data maps with evolving healthcare data uses, including analytics and AI development.

42 CFR Part 2 harmonization

Updates continue to harmonize consent and enforcement concepts between HIPAA and 42 CFR Part 2. Prepare for stricter auditability, finer-grained tagging of SUD data, and clearer redisclosure logic across APIs and data lakes.

Cross-border and Bulk Sensitive Personal Data Transfers

Controls around Bulk Sensitive Personal Data Transfers are tightening, especially for health, genomic, biometric, precise geolocation, and other sensitive attributes. Implement counterparty screening, regionalization, and transfer impact assessments before exporting datasets.

2026 privacy operations checklist

• Adopt de-identification standards with measurable re-identification risk testing; monitor data broker re-enrichment risks.
• Maintain a single source of truth for data lineage, sensitivity labels, and consent states across warehouses and ML feature stores.
• Institutionalize privacy-by-design reviews early in product and partnership lifecycles.

AI and Healthcare Regulations

Medicare Advantage AI Guidelines

Medicare Advantage AI Guidelines emphasize that algorithms cannot replace human clinical judgment in coverage decisions. You should document model use, ensure human-in-the-loop review for adverse determinations, and provide clear explanations to beneficiaries.

Accountability for models and vendors

Create a governance program that inventories models, describes training data, evaluates bias and drift, and sets thresholds for escalation. Contracts must prohibit unconsented reuse of protected health information and require prompt disclosure of model changes that could affect beneficiaries.

2026 readiness steps

• Stand up an AI oversight committee with authority over procurement, validation, monitoring, and decommissioning.
• Produce beneficiary-facing rationales for denials; log clinician overrides and appeals to refine models.
• Segment SUD and other sensitive data so it never trains models without explicit, valid authorization.

Electronic Health Record Compliance

Interoperability and certification

EHR developers and brokers must support secure APIs, robust export of electronic health information, and transparent pricing. Align roadmaps to recognized standards (for example, FHIR-based APIs and the latest USCDI set) to avoid interoperability barriers.

Information blocking safeguards in EHR workflows

Review authentication, patient portal access, and third-party app connections to ensure you are not creating friction that could be viewed as interference. Keep a structured register of practices falling under information blocking exceptions and the evidence supporting each one.

2026 updates to expect

• Deeper transparency for decision support content and provenance within EHR user interfaces.
• Stronger prior authorization interoperability and timelines to reduce administrative burden.
• Expanded testing and attestation requirements that verify real-world, patient-directed data access.

Data Broker Registration and Transparency

Who must register and what to disclose

Entities that collect, license, or sell personal data they did not directly obtain from the consumer may need to register as data brokers. Disclose data categories, sources, sales or sharing practices, opt-out methods, and security posture in plain language.

Provenance, accuracy, and audits

Maintain data provenance so you can prove lawful collection and authorized use. Conduct periodic accuracy checks, suppress known-false records, and publish metrics on request fulfillment and appeals where required.

Contracts and downstream controls

Bind buyers and vendors to purpose limitations, no re-identification of de-identified data, no attempts to infer SUD status, and immediate deletion upon instruction. Require breach notification, subprocessor transparency, and audit cooperation.

2026 transparency measures

• Provide a centralized, verifiable opt-out and deletion interface that scales for California and other states.
• Tag and restrict sensitive attributes to prevent bulk export or transfer to high-risk jurisdictions.
• Publish annual transparency summaries aligning with state-specific content rules.

Consumer Privacy Protections

Individual rights handling

Offer accessible processes to access, correct, delete, and port data, with identity verification proportionate to the risk. Track SLAs, maintain immutable logs, and verify that deletions propagate to backups and downstream partners.

Children, teens, and sensitive categories

Use opt-in for the sale or sharing of sensitive data, including precise geolocation, biometrics, health inferences, and SUD information. Apply heightened protection to minors, tailoring notices and choices to age and comprehension.

Notice, choice, and design

Deliver concise, layered notices describing data uses, retention, and sharing. Honor global privacy controls, provide frictionless opt-outs, and avoid dark patterns that could undermine informed choice.

In summary, successful compliance in 2026 hinges on aligning HIPAA safeguards with 42 CFR Part 2 protections, eliminating information blocking risks, registering and disclosing like a mature data broker, restricting bulk sensitive personal data transfers, and governing AI with human oversight and transparency.

FAQs

What are the key federal regulations affecting healthcare data brokers?

Core regimes include the Health Insurance Portability and Accountability Act for privacy and security; 42 CFR Part 2 for heightened Substance Use Disorder Confidentiality; and information blocking rules governing access, exchange, and use of electronic health information. Together, they require documented policies, consent and redisclosure controls, interoperable APIs, and evidence-backed exceptions.

How do state laws like California’s SB 362 impact data broker compliance?

California’s SB 362 expands Data Broker Registration and centralizes consumer deletion, pushing brokers to standardize identity verification, automate suppression and deletion across systems and vendors, and publicly disclose sources, categories, and rights mechanisms. Many states have similar frameworks, so scale your program to the strictest requirements.

What updates to EHR standards must healthcare IT vendors follow in 2026?

Expect deeper interoperability through FHIR-based APIs, support for the latest USCDI elements, stronger transparency for decision support, and more rigorous real-world testing and attestation. Vendors should also harden patient-directed access and ensure practices do not constitute information blocking.

How does the new enforcement program affect Substance Use Disorder patient record confidentiality?

Enforcement places added emphasis on 42 CFR Part 2 compliance: precise consent capture, redisclosure limits, segmentation of SUD data from general records, and complete audit trails. Programs that blend SUD data into broader datasets without authorization face heightened risk, so implement technical and procedural separation by default.